Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
latest_posts
- 1
Understanding Various Sorts of Financial balances: An Extensive Outline - 2How mountain terraces have helped Indigenous peoples live with climate uncertainty
- 3Medical team successfully delivers baby and removes massive tumor
- 4Supreme Court case about ‘crisis pregnancy centers’ highlights debate over truthful advertising standards
- 5Earth's newfound 'episodic-squishy lid' may guide our search for habitable worlds
- Birds at a college changed beak shapes during the pandemic. It might be a case of rapid evolution
- Health insurance premiums rose nearly 3x the rate of worker earnings over the past 25 years
- Top Music and Dance Celebration: Which One Gets You Going?
- Defense Minister Katz moves to extend IDF service to 36 months
- 5 Different ways Macintosh is Prepared to Overwhelm Gaming, Even Against Windows
- Congo declares its latest Ebola outbreak over, after 43 deaths
- Dental Embed Developments: Upsetting Current Dentistry
- Flourishing as a Charitable Pioneer: Individual Encounters in Generosity
- Authentic Urban areas: Rich Legacy and Lively Societies
